Back to News
Market Impact: 0.5

IONQ or Rigetti: Which is the Better Quantum Bet as 2025 Nears End?

IONQRGTINVDA
Technology & InnovationProduct LaunchesCorporate EarningsAnalyst EstimatesCompany FundamentalsM&A & RestructuringInvestor Sentiment & PositioningInfrastructure & Defense
IONQ or Rigetti: Which is the Better Quantum Bet as 2025 Nears End?

IonQ reported Q3 2025 revenues of $39.9 million, up 222% year-over-year and 37% above guidance, announced a #AQ 64 Tempo milestone, a world-record 99.99% two-qubit gate fidelity, and completed a $2.0 billion equity offering to reach a pro-forma cash balance of roughly $3.5 billion with no debt. Rigetti reiterated an aggressive chiplet-based roadmap (100+ qubits with 99.5% median two-qubit fidelity by end-2025; 150+ by end-2026; 1,000+ by end-2027), booked $5.7 million in purchase orders and a $5.8 million Air Force Research Laboratory contract, and has seen its stock rise 69.4% over three months versus IonQ's 13.6% (S&P +5.7%). Analysts have trimmed 2025 EPS estimates sharply for both firms (IonQ: from -$1.77 to -$5.14; Rigetti: from -$0.09 to -$0.68), leaving IonQ with stronger near-term financial visibility while Rigetti offers higher-beta upside if it delivers on near-term technical milestones.

Analysis

Market structure: IonQ (IONQ) gains from immediate enterprise wins, DOE/Oak Ridge contracts and a pro-forma ~$3.5B cash cushion that lets it invest in Tempo/256‑qubit demos; Rigetti (RGTI) benefits in defense and on‑prem niches with $11.5M of recent orders/contracts but remains revenue-light. NVDA is an indirect beneficiary via NVQLink and hybrid workflows. Supply remains constrained (few viable hardware vendors), so early commercial customers will pay premiums for demonstrated fidelity and integrated solutions, increasing pricing power for milestone achievers and compressing margins for laggards. Risk assessment: Tail risks include missed fidelity/ship milestones (technical), sudden clampdowns on export/defense funding (regulatory), and dilution (> $500M raises) that reset valuations; these are low-probability but high-impact. Near term (days–weeks) focus is on milestone announcements and contract recognitions; short term (months) on Tempo/100+ qubit deliveries; long term (2–3 years) on software stack and enterprise recurring revenue. Hidden dependencies are partner integrations (Oxford Ionics, NVDA) and government budgets — monitor DoE/DOD appropriations and MOUs. Trade implications: For asymmetric upside, favor LEAP-style optionality on Rigetti tied to end‑2025/end‑2026 milestones and defensively sized equity/covered-call exposure to IonQ given its cash runway. Pair trades (long RGTI calls, short small‑quantum cap) capture beta while limiting idiosyncratic risk. Cross‑asset: outperformance should lift high‑yield tech credit spreads tighter; expect elevated options IV on both names around milestone dates — trade premium, not headlines. Contrarian angles: Consensus underestimates IonQ’s non‑compute TAM (sensing, networking, cybersecurity) and may have over‑penalized EPS revisions; conversely, Rigetti’s 69% YTD rally may be pricing in near‑perfect execution and is vulnerable to execution slippage. Historical parallel: early GPU/AI hardware cycles show winners consolidated after capitalized R&D — a likely outcome here if a vendor nails fidelity+scale. Unintended consequence: IonQ’s cash enables M&A that could materially re‑rate the stock; absence of such moves risks mispricing.